Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amarin Pharmaceuticals Inc.

Division of Valeant Pharmaceuticals International/Amarin Pharmaceuticals Inc.
www.amarinpharma.com

Latest From Amira Pharmaceuticals Inc.

J&J’s $30bn For Actelion Buys Immediate And Longer-Term Value

In this tale of two companies, it's the best of times and the best of times. J&J gets immediate value by acquiring Actelion's blockbuster PAH franchise and its late-stage pipeline, while its stake in an Actelion spinout offers longer-term potential.

M & A Deals

Here To Stay: Inception Sciences Shows Why Build-To-Buy Works

Born at a time when venture capital found few exit opportunities for early-stage companies, build-to-buy helped mitigate the risk in investing in uncharted science. But the model is flourishing even in this period of wider capital options.

BioPharmaceutical Strategy

Versant Launches Inception IBD, A New Company With Old Roots

Versant and Celgene have partnered again to launch a build-to-buy biotech, this time focusing on inflammatory bowel disease.

BioPharmaceutical Strategy

Finding Bristol's Next Wave Of Innovation: An Interview With Douglas Manion

With a focus on specialty drugs, Bristol wants to be known for more than immuno-oncology. To that end, specialty development head Douglas Manion is charged with leading innovation in immunology, virology and cardiovascular, genetically defined and fibrotic disease.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Valeant Pharmaceuticals International
  • Senior Management
  • Steve Guillen, VP, Sales & Mktg.
    Michael J Winsor, VP, Fin.
    Bim Strausser, VP, Clinical Dev. & Medical Affairs
    Michael D Coffee, Pres. & COO
  • Contact Info
  • Amarin Pharmaceuticals Inc.
    Phone: (866) 426-2746
    Two Belvedere Pl., Ste. 330
    Mill Valley, CA 94941
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register